Free Trial

Petros Pharmaceuticals (PTPI) SEC Filings & 10K Form

Petros Pharmaceuticals logo
$0.05 0.00 (-4.65%)
As of 09:47 AM Eastern

Recent Petros Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/11/2025
4:22 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:00 PM
Petros Pharmaceuticals (Filer)
Form DEF 14A
03/07/2025
4:06 PM
Petros Pharmaceuticals (Filer)
Form PRE 14A
02/26/2025
8:16 AM
Iroquois Capital Management, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/21/2025
4:30 PM
Bernstein Bruce (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:31 PM
Boctor Fady (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:33 PM
Petros Pharmaceuticals (Issuer)
Silverman Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:34 PM
Arnold Mitchell (Reporting)
Petros Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:36 PM
Petros Pharmaceuticals (Issuer)
WALKER WAYNE REMELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
4:22 PM
Petros Pharmaceuticals (Filer)
Form 424B4
02/17/2025
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
02/14/2025
7:55 PM
Petros Pharmaceuticals (Filer)
Form S-1MEF
02/14/2025
10:28 AM
Petros Pharmaceuticals (Filer)
Form S-1/A
02/13/2025
12:44 PM
Ayrton Capital LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/13/2025
8:42 AM
Petros Pharmaceuticals (Filer)
Form S-1/A
12/16/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
3:57 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:21 PM
Petros Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:11 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
10:14 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
10/25/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form DEF 14A
10/25/2024
4:02 PM
Petros Pharmaceuticals (Filer)
Form ARS
10/18/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:07 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:19 PM
Petros Pharmaceuticals (Filer)
Form PRE 14A
10/04/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
05/15/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTPI) was last updated on 4/23/2025 by MarketBeat.com Staff
From Our Partners